skip to content

School of Pharmacy

UCSF School of Pharmacy
UCSFSchool of PharmacyNews ArchiveSarah Nelson and Marcus Ferrone explain how they are joining forces against prostate cancer

Sarah Nelson and Marcus Ferrone explain how they are joining forces against prostate cancer



Friday, July 8, 2011

You need JavaScript enabled and Adobe Flash Player 8 or newer to view this video. Watch on YouTube

Magnetic resonance imaging (MRI), used with a novel pyruvate chemical compound that is specially labeled to be read by the MRI machine, is being applied for the first time in humans to study the aggressiveness of prostate cancer in patients and the success of prostate cancer therapies. The chemical compound is energized, then quickly injected into the prostate cancer patient before imaging begins.

The UCSF research project brings together the imaging expertise of mathematician and bioengineer Sarah Nelson, PhD, and the pharmacy and compound formulation expertise of pharmacist Marcus Ferrone, PharmD. Nelson is a faculty member in the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine. Ferrone is a faculty member in the Department of Clinical Pharmacy, UCSF School of Pharmacy.

Go to: UCSF School of Pharmacy News

Other news

image preload